← Back to Search

NuestraSaludSegura Program for COVID-19 Testing and Vaccination

N/A
Recruiting
Led By Scott D Rhodes, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
participant must be ≥ 18 years of age
participant must be ≥18 years of age
Must not have
less than 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to address the social, ethical, and behavioral implications of COVID-19 testing and vaccination within Latinx communities in order to increase uptake of these lifesaving interventions.

Who is the study for?
This trial is for Spanish-speaking individuals who are at least 18 years old and self-identify as Hispanic/Latinx. They must provide informed consent to participate. For certain parts of the study, participants also need to have received a COVID-19 vaccination.
What is being tested?
The study aims to understand barriers faced by Latinx communities in accessing COVID-19 testing and vaccinations. It will test 'NuestraSaludSegura', which combines peer navigation with mobile health (mHealth) strategies, designed specifically for Spanish speakers.
What are the potential side effects?
Since this trial focuses on increasing access to testing and vaccination rather than administering drugs or medical procedures, it does not directly involve side effects from interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.
Select...
I speak Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Doses of vaccine received - Johnson and Johnson
Vaccines
Doses of vaccine received - Pfizer
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Spanish-speaking Latinx communitiesExperimental Treatment1 Intervention
Individual in-depth interviews with Spanish-speaking Latinx participants

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
443 Previous Clinical Trials
1,413,141 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,401 Previous Clinical Trials
2,460,195 Total Patients Enrolled
Scott D Rhodes, PhDPrincipal InvestigatorWake Forest University Health Sciences
4 Previous Clinical Trials
792 Total Patients Enrolled

Media Library

Coronavirus Research Study Groups: Spanish-speaking Latinx communities
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top